Randomized controlled trial of sativex, a cannabis based medicine (CBM), in central neuropathic pain due to multiple sclerosis, followed by an open-label extension

Category Primary study
JournalNeurology
Year 2006

This article is included in 2 Systematic reviews Systematic reviews (2 references) 2 Broad syntheses Broad syntheses (2 references)

This article is part of the following publication threads:
This article is part of the following matrixes of evidence:
Loading references information
This article has no abstract
Epistemonikos ID: 9faf42f3d46fab9a283613db0814a2a409ba22fc
First added on: Jul 04, 2015